DXBTIDES / QUALITY REFERENCE
Verify the identifiers first. Match a product or variant code before delivery, then verify a released lot when a public record is available.
Find a document 20 documents
BPC-157 10MG Source document
LOT VL-BPC-2026-0412
Reported purity 99.91%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ GHK-CU 100MG Source document
LOT VL-GHK100-20260319
Reported purity 99.9%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ GHK-CU 50MG Source document
LOT VL-GHK50-20260318
Reported purity 99.89%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ GLOW 70MG Source document
LOT VL-GLOW-20260804
Reported purity 99.88%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ GLP-3 RT 30MG (RETA) Source document
LOT VL-GLP3RT30-20260917
Reported purity 99.91%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ KLOW 80MG Source document
LOT VL-KLOW-20260319
Reported purity 99.89%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ PT-141 10MG Source document
LOT VL-PT141-20260323
Reported purity 99.89%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ TESAMORELIN 10MG Source document
LOT VL-TESA10-20260917
Reported purity 99.9%
Test date 15 July 2026
Reported lab Supplier internal laboratory View certificate ↗ Retatrutide 10 mg Source document
LOT DT-CP-2607-RET10
Reported purity 99.427%
Test date 17 SEP 2026
Reported lab JANOSHIK View certificate ↗ GHK-Cu 50 mg Source document
LOT DT-REPORT-136726
Reported purity 99.425%
Test date 20 APR 2026
Reported lab JANOSHIK View certificate ↗ GHK-Cu 100 mg Source document
LOT DT-CP-2607-GHK100
Reported purity 99.353%
Test date 06 AUG 2026
Reported lab JANOSHIK View certificate ↗ BPC-157 10 mg Source document
LOT DT-RVA-BPC10-001
Reported purity 99.989%
Test date 18 SEP 2026
Reported lab JANOSHIK View certificate ↗ KLOW 80 mg Source document
LOT DT-RVA-KLOW80-001
Reported purity Not included
Test date 18 SEP 2026
Reported lab JANOSHIK View certificate ↗ Wolverine 5 mg + 5 mg Source document
LOT DT-RVA-BT10-002
Reported purity Not reported
Test date 15 SEP 2026
Reported lab JANOSHIK View certificate ↗ Retatrutide 10 mg Source document
LOT DT-RVA-RT10-001
Reported purity 99.827%
Test date 21 SEP 2026
Reported lab JANOSHIK View certificate ↗ GHK-Cu 50 mg Source document
LOT DT-RVA-GHK50-002
Reported purity 99.415%; 99.420%
Test date 14 SEP 2026
Reported lab JANOSHIK View certificate ↗ MOTS-C 40 mg Source document
LOT DT-CP-2605-MOT40
Reported purity 99.266%
Test date 24 JUL 2026
Reported lab JANOSHIK View certificate ↗ GLOW 70 mg Source document
LOT DT-RVA-GLOW70-001
Reported purity 99.54%
Test date 21 JUL 2026
Reported lab FREEDOM DIAGNOSTICS View certificate ↗ PT-141 10 mg Source document
LOT DT-RVA-PT141-001
Reported purity 99.79%
Test date 21 JUL 2026
Reported lab FREEDOM DIAGNOSTICS View certificate ↗ Tesamorelin 20 mg Source document
LOT DT-2026-03-002-K2
Reported purity 99.82%
Test date 24 AUG 2026
Reported lab FREEDOM DIAGNOSTICS View certificate ↗ Check batch release status Product name, variant code or concentration Lot or batch number
Catalogue matches Enter a product name or code to begin.
01 Documentation status Released batch records and supplier-source documents are listed separately here. If a lot does not appear, contact the team before relying on any document or purity claim. A source-vial COA does not certify the prepared pen's final purity or sterility; a pen requires its own preparation and traceability record.
02 Before accepting delivery Match the product and variant code Confirm the printed concentration and packaging Verify the dispatched lot number Keep delivery and handling documentation together 03 Delivery coordination Delivery details and timing are confirmed directly by the team when availability is confirmed.
REQUEST DOCUMENTATION OPEN CATALOGUE How to read the analysis Read the testing source, LOT and test date alongside the result; the document design or purity number alone is not enough to assess it.
Testing source Supplier laboratory testing is internal quality control. Independent testing is performed by an external laboratory unaffiliated with the supplier. Check the testing organization and method in each document; a logo alone does not establish independence.
Purity and identity An HPLC result describes purity within the analytical method used. Identity testing, such as MS or LC-MS, helps identify the compound. Read the method with the result; purity alone does not establish identity or sterility.
Batch traceability Match the LOT on the packaging with the document and test date. A product certificate does not establish that it covers dispatched stock. A prepared pen needs a separate preparation and traceability record from the original material COA.
For batch documents or available analytical data: info@dxbtides.com
Research information only. No medical advice, human-use direction or unverified purity claim is provided here.